OTC Markets OTCPK - Delayed Quote USD

Lotus Pharmaceuticals, Inc. (LTUS)

0.0048
0.0000
(0.00%)
At close: May 9 at 4:00:00 PM EDT
Loading Chart for LTUS
  • Previous Close 0.0000
  • Open 0.0048
  • Bid 0.0048 x --
  • Ask 0.0062 x --
  • Day's Range 0.0048 - 0.0048
  • 52 Week Range 0.0006 - 0.0079
  • Volume 5,000
  • Avg. Volume 12,764
  • Market Cap (intraday) 12.694M
  • Beta (5Y Monthly) -2.58
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0400
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Lotus Pharmaceuticals, Inc. does not have significant operations. Previously, it was engaged in the development, manufacture, and sale of pharmaceuticals in the People's Republic of China. The company is based in Nashville, Tennessee.

lotuspharmaceuticalsusa.com

233

Full Time Employees

December 31

Fiscal Year Ends

Recent News: LTUS

View More

Performance Overview: LTUS

Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

LTUS
20.00%
S&P 500 (^GSPC)
3.77%

1-Year Return

LTUS
19.70%
S&P 500 (^GSPC)
8.55%

3-Year Return

LTUS
65.71%
S&P 500 (^GSPC)
41.81%

5-Year Return

LTUS
67.79%
S&P 500 (^GSPC)
93.18%

Compare To: LTUS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: LTUS

View More

Valuation Measures

Annual
As of 5/9/2025
  • Market Cap

    12.69M

  • Enterprise Value

    12.69M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    2.43%

  • Return on Assets (ttm)

    4.56%

  • Return on Equity (ttm)

    1.82%

  • Revenue (ttm)

    71.39M

  • Net Income Avi to Common (ttm)

    1.72M

  • Diluted EPS (ttm)

    -0.0400

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    158.91k

  • Total Debt/Equity (mrq)

    6.22%

  • Levered Free Cash Flow (ttm)

    -5.29M

Research Analysis: LTUS

View More

Company Insights: LTUS

Research Reports: LTUS

View More

People Also Watch